Addressing Treatment Dilemmas in Neovascular AMD and DME

home / insights / addressing-treatment-dilemmas-in-neovascular-amd-and-dme

An expert retina specialist discusses typical challenging scenarios, including step edits and inadequate responses to anti-VEGF treatment, frequently encountered in managing patients with neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME), and outlines effective strategies to address these issues.

© 2024 MJH Life Sciences

All rights reserved.